These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 32090499)
21. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C. Volonte D; Peoples AJ; Galbiati F Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320 [TBL] [Abstract][Full Text] [Related]
22. A CAV3 microdeletion differentially affects skeletal muscle and myocardium. Cagliani R; Bresolin N; Prelle A; Gallanti A; Fortunato F; Sironi M; Ciscato P; Fagiolari G; Bonato S; Galbiati S; Corti S; Lamperti C; Moggio M; Comi GP Neurology; 2003 Dec; 61(11):1513-9. PubMed ID: 14663034 [TBL] [Abstract][Full Text] [Related]
23. Myotonia associated with caveolin-3 mutation. Milone M; McEvoy KM; Sorenson EJ; Daube JR Muscle Nerve; 2012 Jun; 45(6):897-900. PubMed ID: 22581547 [TBL] [Abstract][Full Text] [Related]
24. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition. Ohsawa Y; Hagiwara H; Nakatani M; Yasue A; Moriyama K; Murakami T; Tsuchida K; Noji S; Sunada Y J Clin Invest; 2006 Nov; 116(11):2924-34. PubMed ID: 17039257 [TBL] [Abstract][Full Text] [Related]
25. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. Galbiati F; Engelman JA; Volonte D; Zhang XL; Minetti C; Li M; Hou H; Kneitz B; Edelmann W; Lisanti MP J Biol Chem; 2001 Jun; 276(24):21425-33. PubMed ID: 11259414 [TBL] [Abstract][Full Text] [Related]
26. Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition. Capanni C; Sabatelli P; Mattioli E; Ognibene A; Columbaro M; Lattanzi G; Merlini L; Minetti C; Maraldi NM; Squarzoni S Exp Mol Med; 2003 Dec; 35(6):538-44. PubMed ID: 14749532 [TBL] [Abstract][Full Text] [Related]
27. Caveolinopathies in Greece. Papadopoulos C; Papadimas GK; Kekou K; Spengos K; Svigou M; Kitsiou-Tzeli S; Manta P Neurologist; 2015 Jul; 20(1):8-12. PubMed ID: 26185955 [TBL] [Abstract][Full Text] [Related]
28. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985 [TBL] [Abstract][Full Text] [Related]